www.adhishthana.com
Analyzing 9 years of U.S. nuclear outage data, the study shows that outages consistently follow our proprietary Adhishthana Principles, forming a Cākra between Phases 4-8 and breaking down systematically in Phase 9.
Analyzing 9 years of U.S. nuclear outage data, the study shows that outages consistently follow our proprietary Adhishthana Principles, forming a Cākra between Phases 4-8 and breaking down systematically in Phase 9.
私たちは、水俣で起きた悲劇的な出来事についての14分間の動画を作るために、100時間以上かけて数え切れないほどの論文や資料を読み込みました。
皆さんのご意見をぜひお聞かせください!
youtu.be/D9UUHSt2_nU
私たちは、水俣で起きた悲劇的な出来事についての14分間の動画を作るために、100時間以上かけて数え切れないほどの論文や資料を読み込みました。
皆さんのご意見をぜひお聞かせください!
youtu.be/D9UUHSt2_nU
Wondering what caused the fall? Check out our latest commentary on what’s driving this and what could be coming next.
Wondering what caused the fall? Check out our latest commentary on what’s driving this and what could be coming next.
If you're wondering why the rally didn’t hold, check out our 13 Nov commentary. We clearly explained why it's likely Nebius will trade with a bearish bias and extended consolidation until at least mid-2027.
If you're wondering why the rally didn’t hold, check out our 13 Nov commentary. We clearly explained why it's likely Nebius will trade with a bearish bias and extended consolidation until at least mid-2027.
📩 shivank@adhishthana[.]com
📩 shivank@adhishthana[.]com
We’d love to hear from experts on methylmercury or the Reppe acetylene hydration process, particularly those based in Japan.
We’d love to hear from experts on methylmercury or the Reppe acetylene hydration process, particularly those based in Japan.
On August 8, our commentary on Middleby Corporation triggered a ~1.98% drop post-release.
Adhishthana Insights are outpacing traditional fund models with remarkable accuracy
On August 8, our commentary on Middleby Corporation triggered a ~1.98% drop post-release.
Adhishthana Insights are outpacing traditional fund models with remarkable accuracy
www.benzinga.com/markets/equi...
www.benzinga.com/markets/equi...
Here's our take:
www.benzinga.com/markets/equi...
Here's our take:
www.benzinga.com/markets/equi...